Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Su, H. Dai, Q. Ye, S. Zhang, C. Ban, M. Zhu (Beijing, China). Potential causes of acute deterioration in patients with interstitial lung disease. Eur Respir J 2010; 36: Suppl. 54, 792

Member's Comments

No comment yet.

Related content which might interest you: Acute exacerbation of interstitial lung diseases as a cause of respiratory failure. Our 3-years experience Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2014 – IPF and surroundings Year: 2014 Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013 Diffuse parenchymal lung diseases presenting with acute hypoxemic failure  Source: International Congress 2017 – Pulmonary emergencies year in review Year: 2017 Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Using the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2015 – IIPs: orphan Year: 2015 Severe fatigue is highly prevalent in patients with interstitial lung disease Source: Virtual Congress 2020 – A fresh look at the spectrum of symptoms in respiratory disease Year: 2020 Walking assessments as the predictor of acute respiratory failure in the interstitial lung disease patients. Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care Year: 2020 Analysis of parameters of lung function in patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 214s Year: 2001 Patients profile and pulmonary rehabilitation in interstitial lung disease Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018 Acute exacerbations of interstitial lung disease Source: Eur Respir Monogr 2016; 74: 117-131 Year: 2016 Autopsy-proven pulmonary determinants in patients with acute respiratory failure Source: Annual Congress 2010 - Intensive care unit outcome Year: 2010 Rituximab treatment of a case of anti-syntetase syndrome with severe interstitial lung disease and acute respiratory failure Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Variability in expression of aquoporine 1 in chronic obstructive pulmonary disease and interstitial lung disease patients Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Predictors of progression in systemic sclerosis patients with interstitial lung disease Source: Eur Respir J, 55 (5) 1902026; 10.1183/13993003.02026-2019 Year: 2020 Clinical features and outcome of patients with acute exacerbation of interstitial pneumonia associated with collagen vascular disease Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Impact of COVID-19 on patients with chronic lung disease Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Differences of acute exacerbations in idiopathic pulmonary fibrosis compared to other fibrotic lung diseases Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease Source: Eur Respir Rev 2009; 18: 129-132 Year: 2009 Clinical course and outcomes of acute exacerbation of fibrosing interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021